Insight

Credibility at a crossroads: why disruption isn’t inevitable 

Healthcare’s most durable competitive advantage is trust, not technology.

A person stands alone on a beach at night, shining a flashlight up into a star-filled sky and the Milky Way above.

Healthcare’s most durable competitive advantage isn’t technology, access, or price. It’s trust. And trust, it turns out, is far more fragile than most leadership teams assume.

The conventional wisdom holds that disruption is something that happens to incumbents. But the more instructive pattern is this: disruption rarely wins because a challenger is better. It wins because an incumbent becomes harder to believe.

Healthcare’s most durable competitive advantage isn’t technology, access, or price. It’s trust.

Credibility is strongest when nothing is changing

For decades, trust in healthcare was structural. It flowed from accreditation, tenure, and institutional reputation. A health system that had been serving a community for fifty years didn’t need to explain itself. Providers and payers extended credibility by default.

That dynamic has shifted fundamentally.

Credibility is now actively evaluated by patients comparing options online, health plan administrators assessing network value, and by prospective employees weighing culture against compensation.

And it’s evaluated across three dimensions simultaneously: clinical expertise, technological capability, and the quality of the consumer experience. Weakness on any one of them creates doubt. Inconsistency across all three is existential.

Growth is where credibility gets stress-tested

Stability preserves trust. Change tests it.

When an organization expands its service portfolio, completes a merger, or begins positioning around a new capability, it creates a gap between what it is and what the market perceives it to be. In calm conditions, that gap closes naturally over time. In competitive conditions, it becomes an opening.

Consider what SimonMed encountered as it expanded beyond diagnostic imaging into prevention and longevity. The clinical evolution was a clear next step in its growth journey. But internal logic is not congruous with market perception.

Without a coherent narrative connecting the capabilities that the organization always had with the company it was becoming, the market risked reading the evolution as a commercial play rather than a clinical one. The strategic work wasn’t to build credibility from scratch. It was to carry existing credibility forward into a new era.

Credibility is now actively evaluated by patients comparing options online, health plan administrators assessing network value, and by prospective employees weighing culture against compensation.

The same stress test shows up as platforms scale. Confluent Health – having grown rapidly as a PE-backed physical therapy platform with dozens of acquired brands – faced a similar problem.

Multiple clinic brand identities work in market, where the main audience is the local patient population. But having different brands from the parent company is less effective for building equity. By underinvesting in the Masterbrand, competitors with clearer brands – even if smaller than Confluent Health – became household names. To better demonstrate its value, Confluent Health invested in a stronger, unified portfolio and an architecture that more clearly frames its scale and credibility for regional and national audiences.

Where credibility fractures

Across these patterns, the fault lines tend to appear in one of two predictable places.

Growth without narrative: expansion outpaces explanation. New services, new markets, new capabilities are added faster than a clear articulation of what it all means. Stakeholders, including employees, are left to construct their own interpretation. That’s rarely favorable.

Building a market story that stakeholders actually believe is crucial. That requires translating operational reality into a coherent external narrative that aligns clinical leadership, communications, and strategy around the same set of honest claims. For healthcare leaders working through exactly that challenge, Brandpie’s upcoming webinar on AI and credibility in healthcare explores what transformation looks like when technology meets human care, and how to communicate it in a way that builds rather than erodes trust.

Culture without alignment: perhaps the most overlooked fracture point is when leadership articulates a strategic direction that doesn’t show up in the day-to-day experience of employees. Patients and partners eventually experience it as inconsistency and over time, that registers as unreliability.

In fact, we often find that the story has not been clearly articulated at all. It often lives in the Founder’s head or is ring-fenced with the leadership team. It’s only when we start our work that we understand how few in the organization are aware of the company vision, or that it hasn’t been crafted and disseminated.

Building a market story that stakeholders actually believe is crucial. That requires translating operational reality into a coherent external narrative that aligns clinical leadership, communications, and strategy around the same set of honest claims.

Making credibility visible

One of the persistent problems in this space is that credibility has traditionally been treated as a lagging indicator, something measured through NPS surveys and reputation rankings, long after the gap has already formed.

The more useful framing is to treat credibility as infrastructure: something designed, monitored, and actively managed. That means having visibility into how the organization is perceived across brand, culture, and experience – not as a one-time diagnostic, but as a continuous operating signal.

The practical implication for CMOs is significant. Brand and culture are often siloed as communications or HR functions. But at moments of strategic change, they function as risk management. A misalignment between what an organization says externally and how it behaves internally doesn’t stay internal for long. It surfaces in patient reviews, in employee attrition, in partner conversations, in the questions boards start asking.

The compounding logic

Credibility compounds. An organization that consistently delivers on its stated identity – clinically, operationally, experientially – builds a reserve that provides genuine insulation against competitive pressure. Disruptors find it harder to gain traction when incumbents are legible, consistent, and trusted.

But the compounding works in reverse, too. A credibility gap, left unmanaged, widens under pressure. What starts as a perception lag during a period of growth – or disruption – can harden into market confusion, then stakeholder doubt, then competitive vulnerability.

The organizations most at risk are the ones scaling complexity faster than they’re scaling coherence, adding services, geographies, and capabilities without the narrative architecture to hold them together. The same is true for legacy companies who’ve been comfortable for a long time, known for one thing,

The disruptors don’t create that condition. They find it, and walk through the door.

Jason Hutt profile

About the author: Jason Hutt, Head of Strategy and Health Lead

Jason has over 20 years experience combining insight and creativity to craft compelling brand strategies that drive growth and inspire audiences across healthcare.

Similar articles